Careteq Ltd (CTQ) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Careteq Ltd A$0.02, price A$0.02, upside +15.0%, quality 41 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Careteq Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
56‑month range A$0.0070 – A$0.1600 · fair‑value band A$0.0166 – A$0.0202 · the A$0.0160 price screens below the A$0.0184 fair value. Dashed = 300-day average. As of Sep 23, 2026.
Follow Careteq in your weekly email
Every Wednesday you see whether Careteq is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Careteq Limited engages in medication management and clinical governance for health, aged, and home care sectors in Australia. The company provides healthcare safety and clinical services. Careteq Limited was incorporated in 2016 and is based in Melbourne, Australia.
Stock analysis
Careteq Ltd (CTQ) currently trades at A$0.0160, while our model-based Fair Value estimate is A$0.0184, implying the stock looks roughly 13.0% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of A$0.0200 per share, and 1 of the 3 models we run sit above the A$0.0160 price.
Bear case: the Multiples group reads lowest at A$0.0100, and 2 of the 3 models stay below the price. Evidence for this calculation is low.
Scenario range: A$0.0166 (bear) to A$0.0202 (bull), the price of A$0.0160 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 41/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Careteq Ltd reported revenue of A$7.6M in FY2025 versus A$735K in FY2021, a compound +79.4%/yr. Reported net income was −A$72.2K in FY2025.
Key figures
Market cap A$8.8M (≈ $6.2M) · P/S ratio 1.16 · Dividend yield 1.0% · Net margin −0.9% · Return on equity −10.9% · Return on assets (EBIT) −19.1% · Operating margin −1,554% · Revenue (TTM) A$7.6M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 16% below its 52-week high and 129% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −45% fair-value upside, at 15%, CTQ screens cheaper than that median.
Fair Value models
Bear A$0.0166Fair Value A$0.0184Bull A$0.0202
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.44/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+5.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+120.4%
Start year 2020 (pandemic)
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−1,341.7% (2020) → 3.0% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 134 stocks
Beats the industry median on 2/9 measures
Overall it trails its industry peers.
Valuation
Quality Score41 · Bottom 25%
Fair Value upside+2% · Above median
Profitability
Return on assets−3% · Below median
Net margin (TTM)−3% · Below median
Growth and dividend
Revenue growth−18% · Bottom 25%
Dividend yield (TTM)1.0% · Bottom 25%
Balance sheet
Debt / equity0.43× · Highest 25%
Valuation Multiplesvs Health Information Services median · lower = cheaper
P/B4.07× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Careteq Ltd Fair Value". https://www.fairvalue-calculator.com/stock/CTQ
Frequently asked questions
Is Careteq Ltd (CTQ) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of A$0.0184 versus a price of A$0.0160, about +15% upside (undervalued).
What is the fair value of CTQ?
Our model-based fair value for Careteq Ltd is A$0.0184 (as of Sep 23, 2026), built from audited fundamentals. The current price: A$0.0160.
What is the quality score of CTQ?
Careteq Ltd has a Quality Score of 41/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Careteq Ltd (CTQ)?
Our model-based price target is the fair value of A$0.0184 (as of Sep 23, 2026) from 4 valuation models. Cautious scenario A$0.0166, optimistic scenario A$0.0202. It is a calculation from audited fundamentals, not an analyst target.
What is the Careteq Ltd stock forecast for 2026?
Our models put fair value at A$0.0184, about +15% upside versus a price of A$0.0160 (undervalued). Cautious scenario A$0.0166, optimistic scenario A$0.0202. The calculation is refreshed regularly with new filings.
What is the revenue of Careteq Ltd (CTQ)?
Careteq Ltd reported trailing-twelve-month revenue of about A$7.6M (latest available figure, as of Sep 23, 2026).
Does Careteq Ltd pay a dividend?
Careteq Ltd currently shows a dividend yield of about 1.02% relative to its recent price (as of Sep 23, 2026).
What is the intrinsic value of Careteq Ltd (CTQ)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Careteq Ltd it is A$0.0184 per share (as of Sep 23, 2026), against a price of A$0.0160. It is the blended result of 4 valuation models (cash flow, earnings, asset, dividend).
Is Careteq Ltd stock overvalued or undervalued in 2026?
As of Sep 23, 2026, CTQ trades below its calculated fair value: price A$0.0160, fair value A$0.0184, a gap of about +15% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CTQ?
No. The price is what the market pays today (A$0.0160); the fair value is what the company's own numbers justify (A$0.0184). For Careteq Ltd the two are A$0.0024 per share apart. That gap is exactly why we show both numbers side by side.
How much is Careteq Ltd worth?
The market values Careteq Ltd at about A$8.8M (market capitalisation, as of Sep 23, 2026). Per share that is A$0.0160; our models calculate a fair value of A$0.0184 per share.
What do the bullish and bearish scenarios say about CTQ?
Our models span a range for Careteq Ltd: cautious scenario A$0.0166, base A$0.0184, optimistic A$0.0202 per share (as of Sep 23, 2026, price A$0.0160). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Careteq Ltd (CTQ)?
Balance-sheet figures for Careteq Ltd (as of Sep 23, 2026): return on equity −10.9%, debt of 0.43 per unit of equity. They feed the Quality Score of 41/100, which measures business quality independently of the share price.
How far is CTQ from its 52-week high?
Careteq Ltd trades at A$0.0160, about 16% below its 52-week high of A$0.0190 and 129% above the low of A$0.0070 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of A$0.0184 is for.
Which stocks are comparable to Careteq Ltd?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, HealthEquity, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Careteq Ltd stock attractive at the current price?
The data as of Sep 23, 2026: price A$0.0160, calculated fair value A$0.0184 (+15%), Quality Score 41/100, from 4 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CTQ calculated?
We run Careteq Ltd through 4 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of A$0.0184, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Careteq Ltd currently trades 15 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Careteq Ltd (CTQ)?
The closing price on Sep 24, 2026 was A$0.0160. Our model-based fair value is A$0.0184, about +15% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Careteq Ltd right now?
The price is below even our cautious bear case (A$0.0166). The market is more pessimistic than our downside scenario. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Careteq Ltd
How large is the market capitalisation of Careteq Ltd (CTQ)?
The market capitalisation of Careteq Ltd is A$8.8M (≈ $6.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Careteq Ltd (CTQ)?
The price-to-sales ratio of Careteq Ltd is 1.16 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Careteq Ltd (CTQ)?
The dividend yield of Careteq Ltd is 1.0%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Careteq Ltd (CTQ)?
The net margin of Careteq Ltd is −0.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Careteq Ltd (CTQ)?
The return on equity (ROE) of Careteq Ltd is −10.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Careteq Ltd (CTQ)?
On an EBIT basis the return on assets of Careteq Ltd is −19.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Careteq Ltd (CTQ)?
The operating margin of Careteq Ltd is −1,554% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Careteq Ltd (CTQ)?
Revenue at Careteq Ltd is growing −18.0% versus a year earlier (3y avg +19.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Careteq Ltd (CTQ) generate?
The free cash flow of Careteq Ltd is −A$805K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Careteq Ltd (CTQ) carry?
The net debt of Careteq Ltd is A$1.3M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Careteq Ltd in the live analysis
One click puts Careteq Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
